Alzstream™ Webinar: Genes to Therapies – One Year Later

Genes to Therapies™: One Year Later

Genes to Therapies™ is the next phase of Cure Alzheimer’s Fund’s long-term plan for attacking Alzheimer’s disease from every possible angle. After locating nearly 100 gene variants that impact Alzheimer’s risk, researchers now plan to investigate the precise function of each gene, the consequence of each variant and precisely how to intervene to arrest the disease process.